<DOC>
	<DOC>NCT01672359</DOC>
	<brief_summary>A six-month study which investigated the effect of Ginkgo Synergy® and Choline or OPC Synergy® and Catalyn® on cognitive and immune function markers and quality of life among healthy older adults with no history of significant cognitive deficits</brief_summary>
	<brief_title>Evaluating Whole Foods Supplementation on Cognition</brief_title>
	<detailed_description />
	<mesh_term>Choline</mesh_term>
	<mesh_term>Grape Seed Extract</mesh_term>
	<criteria>60 years of age and older English speaking Not living in a skilled or intermediate care level nursing facility No use of dietary supplements for cognitive functioning two weeks before enrolling in the study and during the length of the trial A MiniMental State Exam (MMSE) score ≥ 23 A cognitive deficit greater than that indicated according to the MMSE score A clinical diagnosis of AD and/or related disorders A psychiatric diagnosis of schizophrenia, other psychotic disorders, bipolar disorder, major depression with psychotic features, delirium, and alcohol or substance abuse/dependence Bleeding disorders Aphasia or sensory, motor, and/or visual disturbances that would have interfered with psychometric tests Gastrointestinal disorders causing impaired absorption of the study supplements Insulindependent diabetes Major conditions such as cardiovascular, pulmonary, renal, thyroid, hepatic, gastrointestinal, or seizure Hematologic or oncologic disorders treated with chemotherapy in the previous two years Active chemotherapy or radiation treatment for cancer Current cigarette smoking More than three major medical or psychiatric hospitalizations in the past year Diagnosis of a terminal illness A T score &gt; 70 on the Global Severity Index of the Brief Symptoms Inventory (BSI) A score ≥ 29 on the Beck Depression InventoryII (BDI) (15) Prescription and OTC sympathomimetic amines and antihistamines within 2 days of an assessment visit Cognition enhancing drugs consumption such as Donepezil, Rivastigmine, Galantamine, and Tacrine Coumadin, tricyclic antidepressants, antipsychotics, and anticonvulsants Cognitionenhancing supplements, herbs, or antioxidants that could not be stopped during the trial Participating in a concurrent trial for drugs, supplements, or treatment that affects behavior or cognitive function</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>cognitive functioning</keyword>
	<keyword>immune function</keyword>
	<keyword>cytokines</keyword>
	<keyword>growth factors</keyword>
	<keyword>quality of life</keyword>
	<keyword>dietary supplementation</keyword>
	<keyword>Ginkgo biloba</keyword>
	<keyword>Improvement of cognitive function</keyword>
</DOC>